BACKGROUND:Heart rate has been associated with prognosis in patients with heart failure with reduced ejection fraction (HFREF) and sinus rhythm; whether this also holds true in patients with atrial fibrillation (AF) is unknown. HYPOTHESIS: To evaluate cardiac rhythm and baseline heart rate and the influence of outcome in patients with HFREF enrolled in the Cardiac Insufficiency Bisoprolol Study II. METHODS: In total, 2539 patients were stratified according to their baseline heart rhythm (AF or sinus rhythm) and into quartiles of heart rate (≤70 bpm, 71-78 bpm, 79-90 bpm, and >90 bpm). The primary outcome was all-cause mortality. Mean follow-up was 1.3 years. RESULTS:Mean age was 61 years, mean left ventricular ejection fraction was 28%, and 80% were male. A total of 521 (21%) patients had AF at baseline. The risk associated with all-cause mortality for each 5 bpm increase in heart rate in patients with sinus rhythm (hazard ratio [HR]: 1.06, 95% confidence interval [CI]: 1.01-1.11, P = 0.012) was significantly different from those with AF (HR: 1.00, 95% CI: 0.94-1.07, P = 0.90, P for interaction = 0.041). The risk associated with higher heart rate in sinus rhythm was primarily attributable to excess risk in the highest quartile (HR: 1.64, 95% CI: 1.18-2.30, P = 0.003). Allocation to bisoprolol did not modify the interaction between heart rate, rhythm and outcome. CONCLUSIONS: In HFREF patients with AF, a higher heart rate is not associated with increased event rates in contrast to HFREF patients with sinus rhythm.
RCT Entities:
BACKGROUND: Heart rate has been associated with prognosis in patients with heart failure with reduced ejection fraction (HFREF) and sinus rhythm; whether this also holds true in patients with atrial fibrillation (AF) is unknown. HYPOTHESIS: To evaluate cardiac rhythm and baseline heart rate and the influence of outcome in patients with HFREF enrolled in the Cardiac InsufficiencyBisoprolol Study II. METHODS: In total, 2539 patients were stratified according to their baseline heart rhythm (AF or sinus rhythm) and into quartiles of heart rate (≤70 bpm, 71-78 bpm, 79-90 bpm, and >90 bpm). The primary outcome was all-cause mortality. Mean follow-up was 1.3 years. RESULTS: Mean age was 61 years, mean left ventricular ejection fraction was 28%, and 80% were male. A total of 521 (21%) patients had AF at baseline. The risk associated with all-cause mortality for each 5 bpm increase in heart rate in patients with sinus rhythm (hazard ratio [HR]: 1.06, 95% confidence interval [CI]: 1.01-1.11, P = 0.012) was significantly different from those with AF (HR: 1.00, 95% CI: 0.94-1.07, P = 0.90, P for interaction = 0.041). The risk associated with higher heart rate in sinus rhythm was primarily attributable to excess risk in the highest quartile (HR: 1.64, 95% CI: 1.18-2.30, P = 0.003). Allocation to bisoprolol did not modify the interaction between heart rate, rhythm and outcome. CONCLUSIONS: In HFREF patients with AF, a higher heart rate is not associated with increased event rates in contrast to HFREF patients with sinus rhythm.
Authors: Ali Vazir; Brian Claggett; Pardeep Jhund; Davide Castagno; Hicham Skali; Salim Yusuf; Karl Swedberg; Christopher B Granger; John J V McMurray; Marc A Pfeffer; Scott D Solomon Journal: Eur Heart J Date: 2014-11-02 Impact factor: 29.983
Authors: Isabelle C Van Gelder; Hessel F Groenveld; Harry J G M Crijns; Ype S Tuininga; Jan G P Tijssen; A Marco Alings; Hans L Hillege; Johanna A Bergsma-Kadijk; Jan H Cornel; Otto Kamp; Raymond Tukkie; Hans A Bosker; Dirk J Van Veldhuisen; Maarten P Van den Berg Journal: N Engl J Med Date: 2010-03-15 Impact factor: 91.245
Authors: Kevin Damman; Adriaan A Voors; Hans L Hillege; Gerjan Navis; Philippe Lechat; Dirk J van Veldhuisen; Henry J Dargie Journal: Eur J Heart Fail Date: 2010-08-04 Impact factor: 15.534
Authors: Vincent E Hagens; Harry J G M Crijns; Dirk J Van Veldhuisen; Maarten P Van Den Berg; Michiel Rienstra; Adelita V Ranchor; Hans A Bosker; Otto Kamp; Jan G P Tijssen; Nic J G M Veeger; Isabelle C Van Gelder Journal: Am Heart J Date: 2005-06 Impact factor: 4.749
Authors: Vincent E Hagens; Dirk J Van Veldhuisen; Otto Kamp; Michiel Rienstra; Hans A Bosker; Nic J G M Veeger; Jan G P Tijssen; Harry J G M Crijns; Isabelle C Van Gelder Journal: Heart Rhythm Date: 2005-01 Impact factor: 6.343
Authors: Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg Journal: Eur Heart J Date: 2008-09-17 Impact factor: 29.983
Authors: Bart A Mulder; Dirk J Van Veldhuisen; Harry J G M Crijns; Jan G P Tijssen; Hans L Hillege; Marco Alings; Michiel Rienstra; Hessel F Groenveld; Maarten P Van den Berg; Isabelle C Van Gelder Journal: Eur J Heart Fail Date: 2013-06-12 Impact factor: 15.534
Authors: Michiel Rienstra; Kevin Damman; Bart A Mulder; Isabelle C Van Gelder; John J V McMurray; Dirk J Van Veldhuisen Journal: JACC Heart Fail Date: 2013-02-04 Impact factor: 12.035
Authors: Davide Castagno; Hicham Skali; Madoka Takeuchi; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Marc A Pfeffer; John J V McMurray; Scott D Solomon Journal: J Am Coll Cardiol Date: 2012-05-15 Impact factor: 24.094
Authors: Bart A Mulder; Kevin Damman; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Michiel Rienstra Journal: Clin Cardiol Date: 2017-05-17 Impact factor: 2.882
Authors: Nadia Bouabdallaoui; Eileen O'Meara; Virginie Bernier; Michel Komajda; Karl Swedberg; Luigi Tavazzi; Jeffrey S Borer; Michael Bohm; Ian Ford; Jean-Claude Tardif Journal: ESC Heart Fail Date: 2019-10-08
Authors: William T Abraham; Jonathan P Piccini; Christopher Dufton; Ian A Carroll; Jeffrey S Healey; Christopher M O'Connor; Debra Marshall; Ryan Aleong; Dirk J van Veldhuisen; Michiel Rienstra; Stephen B Wilton; Michel White; William H Sauer; Inder S Anand; Sophia P Huebler; Stuart J Connolly; Michael R Bristow Journal: Heart Rhythm O2 Date: 2021-11-14